Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets
Go back to Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1107.08 +5.00 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 256.27 | |||
| Day Low | $1079.22 | EPS | $4.32 | |||
| Volume | 3,314,672 | |||||
| (NYSE: OGN) | Delayed: 13.45 +0.05 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.40 | 52 Week High | $8.00 | |||
| Open | $13.40 | 52 Week Low | $8.00 | |||
| Day High | $13.46 | P/E | N/A | |||
| Day Low | $13.39 | EPS | $0.00 | |||
| Volume | 1,533,729 | |||||

